COURTNEY SOULSBY
Global Director, Healthcare sector, BSI, London, United Kingdom

Global donor (pharmaceutical) organizations face a myriad of challenges and risks in their supply chains when monitoring donations of essential medical supplies to low-middle-income markets. Product diversion, improper storage and distribution conditions, quality excursions, expiration of products, and product tampering all put patients’ health at risk and impact donor organizations negatively in several ways. All of these supply chain risks prohibit the original intent of these donations – increasing access to medicines for patients in the low- and middle-income countries (LMICs).

It’s been acknowledged across the donated medicines market that the best way to overcome these challenges is to improve the visibility of medicines along the supply chain and capabilities of those involved. Improvements in supply chains lead to dramatic advancements in utilization of donated medicines, ensuring the products reach their intended patients – the true value indicator of the donor organization.

Made possible by the advent of Web3 (or the Internet of the 3rd generation), OriginTrail Decentralized Knowledge Graph brings to life a new type of assets, rep ...